Article info

Extended report
Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study

Authors

  1. Correspondence to Professor T W J Huizinga, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Leiden 2300 RC, The Netherlands; t.w.j.huizinga{at}lumc.nl
View Full Text

Citation

Huizinga TWJ, Conaghan PG, Martin-Mola E, et al
Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study

Publication history

  • Received April 15, 2014
  • Revised July 21, 2014
  • Accepted August 10, 2014
  • First published August 28, 2014.
Online issue publication 
December 04, 2014

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.